Funding Rounds
Vicebio

Vicebio Series B Round, September 2024

Vicebio

Developer of novel vaccines for respiratory viral infections.

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series B

Raised Amount: $100.00M

Raised Date: 2024-09-23